Impact of aspirin and clopidogrel hyporesponsiveness in patients treated with drug-eluting stents: 2-year results of a prospective, multicenter registry study

TD Stuckey, AJ Kirtane, BR Brodie… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study

ADAPT-DES Investigators - JACC …, 2017 - ohiostate.elsevierpure.com
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study

TD Stuckey, AJ Kirtane, BR Brodie… - JACC …, 2017 - pubmed.ncbi.nlm.nih.gov
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.

TD Stuckey, AJ Kirtane, BR Brodie… - JACC …, 2017 - europepmc.org
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study

ADAPT-DES Investigators - JACC: Cardiovascular …, 2017 - pure.johnshopkins.edu
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study

ADAPT-DES Investigators - JACC: Cardiovascular …, 2017 - jhu.pure.elsevier.com
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

[引用][C] Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents

TD Stuckey, AJ Kirtane, BR Brodie… - JACC: Cardiovascular …, 2017 - cir.nii.ac.jp
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting
Stents | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study

TD Stuckey, AJ Kirtane, BR Brodie… - JACC …, 2017 - experts.umn.edu
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …

[HTML][HTML] Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry …

TD Stuckey, AJ Kirtane, BR Brodie… - JACC: Cardiovascular …, 2017 - Elsevier
Objectives In this analysis of 2-year outcomes in the ADAPT-DES (Assessment of Dual
AntiPlatelet Therapy with Drug-Eluting Stents) study, the authors sought to examine the …